A 3'-UTR KRAS-variant is associated with cisplatin resistance in patients with recurrent and/or metastatic head and neck squamous cell carcinoma.

ABSTRACT: To determine the differential expression of KRAS-variant HNSCC (head and neck squamous cell carcinoma) cell lines. Total RNA collected from a panel of HNSCC cell lines.

ORGANISM(S): Homo sapiens

SUBMITTER: Elana Fertig 

PROVIDER: E-GEOD-36110 | biostudies-arrayexpress |

REPOSITORIES: biostudies-arrayexpress